Shanghai Pharmaceuticals' shareholder stake exceeds 37%
Shanghai Pharmaceuticals Holding Co., Ltd. (SSE:601607) announced that its controlling shareholder, Shanghai Industrial Holdings (SIH), and its concerted person, SIIC Investment, increased their stake in the company. On April 30, 2025, SIH, through its wholly-owned subsidiary SIIC Investment, acquired 1,000,000 H shares of Shanghai Pharmaceuticals. Before this equity change, SIH held 1,371,116,337 shares, accounting for 36.974% of the total share capital. After the increase, SIH's holdings rose to 1,372,116,337 shares, representing 37.001% of the total share capital of 3,708,361,809 shares. The shares were acquired through centralized bidding on the secondary market. The change in equity does not trigger a takeover bid and will not affect the company's listing status or change its controlling shareholder. This increase aligns with the previously disclosed shareholding increase plan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Pharmaceuticals Holding publishes news
Free account required • Unsubscribe anytime